Skip to main content

Advertisement

Table 1 Baseline characteristics of the investigated hepatocellular carcinoma patients

From: Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Characteristic Hepatectomy-TACE group (n = 116) Hepatectomy Alone group (n = 118) P-value
Age [years; median (range)] 44.0 (18–75) 48.5 (18–74) 0.112
Gender [cases (%)]
 Male 106 (91.4) 106 (89.8) 0.824
 Female 10 (8.6) 12 (10.2)
ECOG performance status [cases (%)]
 0 48 (41.4) 53 (44.9) 0.794
 1 65 (56.0) 63 (53.4)
 2 3 (2.6) 2 (1.7)
Serum HBsAg [cases (%)]
 Positive 94 (81.0) 101 (85.6) 0.384
 Negative 22 (19.0) 17 (14.4)
Preoperative serum AFP [cases (%)]
 < 25 ng/mL 37 (31.9) 36 (30.5) 0.888
 ≥ 25 ng/mL 79 (68.1) 82 (69.5)
Hemoglobin (g/L; mean ± SD) 142.3 ± 23.7 141.2 ± 24.4 0.711
Platelet (× 109/L; mean ± SD) 205.2 ± 79.1 178.6 ± 80.0 0.119
Alanine aminotransferase (U/L; mean ± SD) 55.3 ± 57.4 45.1 ± 27.9 0.086
Serum albumin (g/L; mean ± SD) 41.4 ± 5.7 41.6 ± 3.4 0.741
Serum total bilirubin (mol/L; mean ± SD) 14.4 ± 5.8 17.3 ± 24.6 0.212
Prothrombin time (s; mean ± SD) 12.2 ± 1.2 12.2 ± 1.1 0.725
Child–Pugh grade [cases (%)]
 Class A 116 (100.0) 116 (98.3) 0.498
 Class B 0 (0.0) 2 (1.7)
Serum urea (mmol/L; mean ± SD) 5.0 ± 1.6 5.2 ± 1.3 0.378
Serum creatinine (μmol/L; mean ± SD) 78.1 ± 24.4 73.8 ± 15.5 0.114
  1. Continuous variables were compared by Student t-test; categorical variables are compared by the χ2 test or the Fisher’s exact test
  2. Hepatectomy-TACE: radical hepatectomy followed by adjuvant transcatheter arterial chemoembolization; Hepatectomy Alone: had undergone only radical hepatectomy; HBsAg: hepatitis B surface antigen; AFP: alpha-fetal protein; SD: standard deviation